It was proposed that a similar mechanism is responsible for plasma gelsolin reduction in other neurological disorders with highly inflammatory components, such as multiple sclerosis (MS), in which actin-mediated depletion of gelsolin in blood (but not in CSF samples) was found and reported by Kułakowska et al. [67]. This evidence concerns the gene GSN and myeloid sarcoma.